Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

621.63
+33.385.68%
Number of Gainers:128
Number of Losers:25
Number of Flat:14
PE:- -
High:623.47
Open:589.37
Low:589.37
Close:588.25
Volume:355.12M
Turnover:11.45B
Market Cap:465.53B
Float Cap:335.53B

Loading ...

What Is Coinbase? A Strategic Review of the “Everything Exchange” in 2026

TradingKey
·
Mar 30

Dallas Fed Business Activity Index Registers -0.2 for March, Down from Prior 0.2

Deep News
·
Mar 30

Infant Bacterial Therapeutics Calls 2026 AGM With Focus on Governance, Capital and Incentives

TIPRANKS
·
Mar 30

Quince Therapeutics Eliminates EIB Debt, Boosts Flexibility

TIPRANKS
·
Mar 30

London developers call for emergency measures in office space squeeze

cityam
·
Mar 30

Does Doximity’s (DOCS) Scale With Physicians and Cash Flow Redefine Its Healthcare Tech Moat?

Simply Wall St.
·
Mar 30

BRIEF-Oklo, Blykalla To Expand Strategic Partnership Through U.S. Investment And Collaboration

Reuters
·
Mar 30

Why Is Viridian Therapeutics Stock Falling Monday?

Benzinga_recent_news
·
Mar 30

Viridian Therapeutics falls -33.5%

TIPRANKS
·
Mar 30

Waterdrop files Form 3 as director Feng Heping reports beneficial ownership

Reuters
·
Mar 30

Analysts Offer Insights on Financial Companies: Coinbase Global (COIN) and Corebridge Financial, Inc. (CRBG)

TIPRANKS
·
Mar 30

BRIEF-Sight Sciences U.S. District Court Issued Order On Post-Trial Motions In Patent Infringement Case Against Alcon Originally Filed On Sep 16, 2021

Reuters
·
Mar 30

Intapp announces Buchanan Ingersoll & Rooney has chosen to adopt Intapp Terms

TIPRANKS
·
Mar 30

Methanol Futures Contract Drops 3% in Day Trading

Deep News
·
Mar 30

Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Atara Biotherapeutics (ATRA) and Rezolute (RZLT)

TIPRANKS
·
Mar 30

Robinhood Markets Is Maintained at Outperform by Bernstein

Dow Jones
·
Mar 30

Coinbase Is Maintained at Outperform by Bernstein

Dow Jones
·
Mar 30

HighTide Therapeutics Highlights HTD1801’s Potential as Foundational CKM Therapy in 2025 Results

TIPRANKS
·
Mar 30

Lenz CFO Daniel Chevallard acquires 7,500 common shares for $64,275

Reuters
·
Mar 30

Lenz CEO Evert Schimmelpennink acquires $0.25 million in common shares

Reuters
·
Mar 30